2018 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Induction Therapy

Date: Monday, June 4, 2018

Time: 2:30pm-4:00pm

Location: Room 6C

Session Type: Concurrent Session

Meeting: 2018 American Transplant Congress

2:30pm-2:42pm: Alemtuzumab is Associated with Higher Rates of De Novo Donor Specific Antibody (DSA) in Patients with No Pre-Transplant DSA

N. Bath, S. Parajuli, G. Leverson, M. Jorgenson, J. Fose, T. Ellis, D. Kaufman, A. Djamali, R. Redfield.

2:42pm-2:54pm: Decreased Long-Term Survival with Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.

2:54pm-3:06pm: Thymoglobulin Induction in HIV Positive Kidney Transplant Recipients: Report on Transplant and HIV Outcomes

E. Gibney, T. Ommert, R. Cross, A. Ray, J. Lizcano.

3:06pm-3:18pm: Effect of Induction Therapy on CD4 Cell Count Recovery Following Renal Transplantation in HIV Positive Recipients – A Single Center Experience

J. Chique Figueroa, M. Prendergast, H. Wadei, M. Mai, K. Oshel, D. Leonard.

3:18pm-3:30pm: Thymoglobulin Induction Decreases Risk of Death in HLA-Sensitized Kidney Recipients

C. Loheac, O. Aubert, M. Assayag, D. Viglietti, C. Lefaucheur, A. Loupy.

3:30pm-3:42pm: Clinical and Pathological Findings in Hepatitis C Positive Renal Transplant Recipients Following Alemtuzumab Induction

S. Jonchhe, J. Husson, A. Haririan, B. Ravichandran.

3:42pm-3:54pm: Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft Function

S. Bernd,² P. Heeger,¹ T-.P. Heather,³ I. Hall,⁷ M. Doshi,⁴ F. Weng,⁵ P. Reese,⁶ C. Parikh.³

« View all sessions from the 2018 American Transplant Congress